Aims/hypothesis Minimal model analysis for insulin sensitivity has been validated against the glucose clamp and is an accepted method for estimating insulin sensitivity from IVGTT. However minimal model analysis requires a 3 h test and relevant expertise to run the mathematical model. The aim of this study was to suggest a simple predictor of minimal model analysis index using only 1 h IVGTT. Methods We studied participants with different clinical characteristics who underwent 3 h regular (n=336) or insulin-modified (n=160) IVGTT, or 1 h IVGTT and euglycaemic-hyperinsulinaemic clamp (n=247). Measures of insulin sensitivity were insulin sensitivity index estimated by minimal model analysis (S I ) and the mean glucose infusion rate (clamp) (M). A calculated S I (CS I ) predictor,
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Introduction
Insulin sensitivity is paramount for characterising metabolic states. The glucose clamp is the experimental procedure yielding the gold standard measurement of this variable. Nonetheless, minimal model analysis of IVGTT data, i.e. insulin sensitivity index estimated by minimal model analysis (S I ), is also widely used to assess insulin sensitivity [1, 2] . However, despite some efforts to develop automatic procedures and lower the need for user intervention [3] , the minimal model procedure requires sophisticated computer programming and relevant expertise to run the mathematical model properly. Furthermore, reliable results based on minimal model require many plasma insulin and glucose samples over a time interval of at least 3 h after glucose injection.
The aims of this study were: (1) to propose an index able to predict minimal model insulin sensitivity values based on direct calculations from easily measurable simple variables and not requiring complex mathematical models, while using IVGTT data limited to 1 h or less, as often happened before introduction of the minimal model [4] ; and (2) to validate the new index against minimal model S I and the glucose clamp, by assessing its performance in several groups of participants with different degree of glucose tolerance and specific clinical characteristics.
Methods
Participants analysed in this study are presented in the following sections. All participants gave their consent to the investigations, which were approved by the Local Ethics Committees.
Participants, 3 h regular IVGTT We analysed 336 participants partially studied in previous investigations [5] [6] [7] [8] . Of these, 114 were control participants with normal glucose tolerance (NGT), 128 had impaired glucose tolerance (IGT) (22 of whom also had impaired fasting glucose) and 22 had type 2 diabetes (Table 1 ). The type 2 diabetes patients (diabetes duration 6.2±0.4 years) were diet-controlled; none of them were taking oral hypoglycaemic agents or insulin. We also analysed 52 participants with chronic renal disease from diabetic nephropathy, nine patients with hyperparathyroidism before and after parathyroidec- Table 1) . Some of these participants were under pharmacological treatment, with gemfibrozil [10] , sulfonylurea or biguanide preparations [11] .
Participants, 1 h IVGTT and clamp We analysed 247 participants from the Botnia study [13] , the EUGENE2 study [14] and another study [15] . All these participants underwent IVGTT (for at least 1 h) and 2 h euglycaemichyperinsulinaemic glucose clamp. Among participants undergoing the clamp, 171 had NGT (NGT CL ), 55 had impaired glucose metabolism (IGM CL ), i.e. either impaired fasting glucose or IGT or both, and 21 had type 2 diabetes (Table 1) . Seven participants in the type 2 diabetes clamp group had severe obesity and subsequently underwent bariatric surgery (here we only report data before surgery).
Calculation of insulin sensitivity In the participants with regular and INSMOD data, insulin sensitivity index was estimated by minimal model analysis (S I ). In the participants with the clamp, insulin sensitivity was calculated as the mean glucose infusion rate (M) over the last 40 min of the test. For all participants, we calculated a surrogate index of S I , called calculated S I (CS I ), with an expression similar to that originally proposed by Galvin et al. [16] . Justification of the difference between our approach and that of Galvin et al. [16] is discussed later. For the participants with regular IVGTT the expression for CS I was:
where a is a constant (scaling factor), K G is the rate of glucose disappearance (slope of log glucose), ΔAUC INS is the AUC of insulin concentration above basal value and T is the time interval between 10 and 50 min (=40 min) when K G and ΔAUC INS are computed. Initial time interval was not zero to avoid possible confounding effects due to mixing. The a constant was assumed equal to the slope of the regression line between the factor K G /(ΔAUC INS /T) and S I in the control group, i.e. a =0.276. This value was used to calculate CS I in all the participants analysed in this study, including those undergoing INSMOD rather than regular IVGTT or clamp.
For the participants with INSMOD the expression for CS I was:
It is well known that the action of exogenous insulin on glucose disappearance is delayed [17] , and hence we assumed a 5 min delay. Since insulin was injected at 20 min, K G1 and ΔAUC INS1 were computed between 10 and 25 min, whereas K G2 and ΔAUC INS2 were computed between 25 and 50 min.
Statistical analysis Relationships between S I and CS I were investigated by linear regression analysis with no intercept. Difference between the mean value of S I and CS I in each of the different groups of participants was assessed through the paired t test. The same test was used to assess difference in insulin sensitivity in the hyperparathyroidism group before and after surgery. Difference in the mean value of each index among different groups was assessed through ANOVA. Similarly, we analysed the relationship between CS I and M by linear regression and used ANOVA to assess differences of both indices among different groups. Relationships between some variables were also investigated by accounting for measurement errors for both variables in the regression [18] . Normality of distributions was assessed before testing for possible differences in insulin sensitivity indices. In case of non-normal distributions, tests were performed on logarithmically transformed values (this applied to the majority of cases, except hyperparathyroidism and former type 1 diabetes groups). p<0.05 was considered statistically significant. Values are reported as mean±SE. (Fig. 1 ). In the type 2 diabetes group the correlation between S I and CS I , though weaker than in the other groups, was still significant (R 2 =0.68, p<0.0001), despite the fact that CS I overestimated S I (slope=1.75, 95% CI 1.21-2.29). When the participants were considered all together, the correlation remained highly significant (R 2 =0.84, p<0.0001, slope=0.99, 95% CI 0.94-1.04).
Results
Minimal model and CS I analyses of regular IVGTT
In each group, mean values of S I and CS I (Table 1) were not different except for the type 2 diabetes and hyperparathyroidism after surgery groups, which showed a slight difference as shown by p values (Table 1) . Bland-Altman plot for all the participants (Fig. 2a) proved substantial equivalence between the two measurements. The absolute difference between S I and CS I in relation to the AUC of insulin in the time interval T (Fig. 2b) showed that only at low insulin levels did S I and CS I tend to diverge. ANOVA showed that S I was different between control and all the other groups (p<0.03) except for the hyperparathyroidism after surgery group. Significant differences were also found in the renal disease vs IGT and type 2 diabetes groups (p<0.0001), and in the hyperparathyroidism after surgery vs IGT and type 2 diabetes groups (p<0.0006). Similar results were found for CS I (p value range: p<0.0001 to p=0.0313), except for comparisons of type 2 diabetes with the other groups. It is worth noting the difference in insulin sensitivity between hyperparathyroidism before and after surgery: as expected, S I was increased after surgery (p=0.021) ( Table 1) and similar results were found with CS I (p=0.008).
In the control group, we calculated the relationships between insulin sensitivity and acute insulin response to glucose (AIR G ) (mean insulin value above basal in the 0 to 8 min period of the IVGTT). Both S I and CS I showed with AIR G a weak but significant nonlinear inverse relationship, which was better appreciated after performing linear regression analysis on logarithmically transformed values (R 2 =0.19, p=0.0002 for S I ; R 2 =0.09, p=0.0009 for CS I ) (Fig. 3) . According to ordinary least-squares regression analysis, the relationship was not strictly hyperbolic, but it was similar with both indices. However, when the analysis was carried out through a regression method accounting for measurement errors in both variables, the relationship turned out to be hyperbolic, as the 95% CI for the slope included −1 for S I (slope: −1.33, 95% CI −2.08, −0.59) and CS I (slope: −1.25, 95% CI −2.15, −0.35).
In all the participants, we also analysed insulin sensitivity with respect to BMI. As expected, S I showed an inverse relationship with BMI; in fact, after log-log transformation, a weak but significant linear regression was observed (R 2 =0.19, p<0.0001), although the relationship was not hyperbolic (according to both regression methods). Similar results were found for CS I (R 2 =0.18, p<0.0001). Participants were then classified as lean or overweight according to their BMI (threshold 25 kg/m 2 ). Both S I and CS I showed significant differences in insulin sensitivity between the two groups (S I =4.65±0.32×10 (Fig. 4a) . Bland-Altman plot showed that only a few samples were outside the limits for equivalence (Fig. 4b) . The paired t test showed a borderline p value (Table 1) . We also classified the participants as obese or non-obese. Since BMI was quite high on average (BMI=29.7±0.4 kg/m 2 ), we assumed 27.5 as threshold between the two groups. As expected, S I was higher in the non-obese group, with similar results found for CS I , p<0.0001). As regards possible differences related to sex, neither M nor CS I showed any difference (p>0.07). In a subgroup of participants, we corrected M for the steady- ), multiply by 0.1667 state insulin level, but results did not change significantly (not shown). It is worth noting that in the small group of type 2 diabetes clamp participants with severe obesity, 3 h IVGTT data were available, thus S I was computed. As expected, we found agreement between S I and M, with regression coefficient value (R 2 =0.63, p=0.018) similar to those observed between CS I and M, as reported above. In this specific subgroup, CS I showed a very strong relationship with M (R 2 =0.95, p<0.0001).
Discussion
The simple index of insulin sensitivity introduced and validated here (CS I ) was revealed to be a good surrogate of that from the well accepted and widely used minimal model (S I ). To our knowledge, only the study of Galvin et al. [16] suggested a simple index for the assessment of insulin sensitivity from IVGTT limited to 1 h. CS I reflects similar concepts, i.e. the quantification of glucose disappearance rate per changes of insulin, but it overcomes some limitations of that study. In fact, Galvin et al. [16] studied the correlation of their index with S I (and also with insulin sensitivity by the glucose clamp), but they did not seek to obtain indices really comparable, their units being different.
In addition, they did not present any strategy to correct their index and make it comparable with S I derived from insulinmodified IVGTT. In contrast, CS I includes a time (T) factor (see Eq. 1) yielding the same units as S I and was adapted to be used also with the insulin-modified test (Eq. 2). Furthermore, in Galvin et al. [16] , the slopes of the regression lines were far from one and different in every group. Moreover, only small groups of participants were studied (with no diabetic patients) and it was not shown whether their index has abilities, similar to S I , to discriminate between groups or clinical conditions with different degrees of insulin resistance. The Galvin index [16] was then used by Anderson et al. [19] , but with essentially the same limitations, which probably prevented its diffusion.
Prior to this study, we used calculations similar to those for CS I to compute a sensitivity index in mice [20] , although not with exactly the same formula and without comparison with the clamp. After correcting our index with a factor derived from regression analysis of the control group (quite a large group, with a wide range of insulin sensitivity), several other groups of participants with different degrees of ), multiply by 0.1667 glucose tolerance and heterogeneous clinical characteristics were analysed. In the majority of groups, we found a good correlation between S I and CS I , and also CS I values similar to S I , as mirrored both by the slope of the regression lines, which were not (or only slightly) different from 1 (see 95% CI), and by the not significantly different mean values. The correction factor a included in the CS I expression was introduced to scale the values of our new index to those calculated with the minimal model. Thus, the interpretation of results obtained by CS I will be facilitated, given the previous wide experience with S I . This correction factor does not have a specific physiological meaning, similarly to the variables included in other empirical methods for the calculation of insulin sensitivity, such as HOMA-insulin resistance (IR) [21] or Stumvoll's index [22] . The relevant aspect of the scaling operation was that the same value of the correction factor (a =0.276) was proved to be appropriate in every group of participants (except type 2 diabetes, as discussed below). In fact, all the results were obtained by using the same correction factor in each group that underwent the regular IVGTT. The same a value was also proved correct in those groups of participants who underwent INSMOD (type 2 diabetes INSMOD) or the clamp (NGT CL , IGM CL , type 2 diabetes clamp).
The comparison between S I and CS I was not completely satisfactory in type 2 diabetes (regular IVGTT). The fact that in situations of high insulin resistance CS I tended to overestimate S I is an important issue and should be discussed within the frame of basic questions, such as: how reliable is a low S I ? This has been much debated among investigators using IVGTT [23, 24] . Thus, we acknowledge that, in situations of low insulin sensitivity, CS I may suffer from inaccuracy, but S I may also exhibit inaccuracy in those conditions [24, 25] . As regards our data, insulin levels in the type 2 diabetes group were usually low, but tended to remain higher than the fasting value: i.e. insulin levels did not return to the basal value during the whole 3 h IVGTT time interval. Thus, in the minimal model approach, the analysis of the last part of the IVGTT tended to decrease the S I value. Since the last part of the complete test is not accounted for by CS I , some discrepancy between the two indices may occur. On the other hand, the finding that in the majority of groups CS I behaves similarly to S I suggests that the information provided by the last part of the IVGTT is usually consistent with that provided by the first part, where CS I is calculated.
Due to the unsatisfactory results in the type 2 diabetes group, we adapted the CS I expression to make it usable with data from the insulin-modified IVGTT as recommended in conditions of poor insulin response [26] . We analysed a large group of type 2 diabetic patients subjected to INSMOD where, as expected, CS I and S I showed low values of insulin sensitivity. They also exhibited a strong correlation with regression slope almost identical with 1, confirming that when dealing with low insulin sensitivity it is recommended to carry out the insulin-modified test even with the short 1 h protocol. We also analysed 208 insulinmodified IVGTT from 146 women with a history of gestational diabetes, who were non-diabetic at the time of examination [27] . We found strong relationship between S I and CS I , with R 2 =0.93 and slope of the regression almost equal to 1 (not shown). However, in non-diabetic participants the regular IVGTT has proven adequate for calculating CS I with sufficient accuracy; hence the insulin-modified protocol is not strictly necessary in these participants. It should be noted that other possible expressions were tested for the calculation of CS I with the insulin-modified IVGTT, such as the average between
, with T1=15 and T2=25 min, and also the second expression alone (i.e. only post-injection information). However, the best results in diabetic and nondiabetic participants were obtained by combining pre-and post-injection information as in Equation (2).
CS I was able to reproduce known findings related to insulin sensitivity. The existence of nonlinear inverse (hyperbolic) relationship between insulin sensitivity and insulin release was postulated some years ago [28] and several subsequent studies [29] have confirmed this finding, although it has recently been suggested that the hyperbola may not be evident in some groups of participants [30] [31] [32] . Our control group exhibited a weak, but still significant inverse relationship between insulin sensitivity and AIR G . According to traditional regression analysis, the relationship was not strictly hyperbolic, but when a more refined regression model was used the hyperbolic relationship emerged. It is worth noting that S I and CS I provided similar results in both cases. Insulin sensitivity was higher in lean than in overweight or obese participants with both indices, which also showed a nonlinear inverse relationship (though weak) with BMI, in agreement with previous studies [33] . As regards the effect of sex on insulin sensitivity, results from S I and CS I were again similar and in agreement with previous studies [34] .
Even though a good agreement was found between S I and CS I , we aimed to validate CS I against the measurement obtained from the glucose clamp. CS I exhibited a good degree of correlation with M and a similar ability to discriminate between participants with different glucose tolerance, as well as between lean and overweight participants. This agreement with the clamp further strengthened the ability of CS I to describe insulin sensitivity in different metabolic conditions.
In this study we included three groups of type 2 diabetic patients. As regards the type 2 diabetes and type 2 diabetes INSMOD groups, it must be noted ( Table 1 ) that both S I and CS I were higher in the former than the latter (p<0.0001 by ANOVA). This possible inconsistency warrants further comment. First, it cannot be excluded that this difference in insulin sensitivity was real, since type 2 diabetic populations may be significantly heterogeneous [35] . On the other hand, as already pointed out, S I may be inaccurate in participants with low insulin values, and CS I exhibits similar limitations in those conditions. Another confounding factor may be the fact that the type 2 diabetes and type 2 diabetes INSMOD groups were studied in different laboratories, probably using different insulin assays: this remains a problem known to be a possible source of error [36] . In any case, we believe that the lower insulin sensitivity in the type 2 diabetes INSMOD than in the type 2 diabetes group may not be an artefact: in fact, HOMA-IR was also clearly higher in the former (7.85 vs 3.47 [non-dimensional], p<0.007), possibly also due the much higher BMI (Table 1) . Similar comments hold for the significant difference in CS I values (p<0.0001) between IGT and IGM CL .
In conclusion, although the minimal model analysis remains the reference method to assess insulin sensitivity from the 3 h IVGTT, the proposed simple, empirical index CS I generally proved to be a reliable index. In the condition of low insulin sensitivity, quite common in type 2 diabetes, analysis of insulin-modified rather than regular IVGTT data should be performed to obtain more reliable estimations, although it is known that in such conditions the assessment of insulin sensitivity becomes intrinsically more uncertain and possibly inaccurate. The great advantage of CS I is that it allows assessment of insulin sensitivity from IVGTT data limited to 1 h, which cannot be analysed with the minimal model. The possibility of analysing less expensive short IVGTTs makes performance of the test easier and less of a burden for participants and investigators, allowing in larger populations the simultaneous assessment of insulin sensitivity and beta cell function (e.g. AIR G variable) with a simple approach. CS I also allows retrospective studies on all the short IVGTTs commonly performed before the introduction of the minimal model.
